Literature DB >> 791093

Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.

M H Richmond, S Wotton.   

Abstract

The properties of cefazolin, cefoxitin, cefamandole, and cefuroxime have been compared with those of cephaloridine, cephalothin, and cephalexin. The properties included for examination are the susceptibility to a range of beta-lactamases commonly encountered in gram-negative species and the ability of a beta-lactam antibiotic to penetrate the outer layers of Escherichia coli. Of the antibiotics tested, cefamandole was the most active in its antibiotic activity but had the disadvantage that it was sensitive to hydrolysis by type IVc beta-lactamase. Cefoxitin and cefuroxime were slightly less active than cefamandole but were effectively resistant to all the beta-lactamases used in the test.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791093      PMCID: PMC429724          DOI: 10.1128/AAC.10.2.219

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Penicillin resistance in Escherichia coli K12: synergism between penicillinases and a barrier in the outer part of the envelope.

Authors:  H G Boman; K Nordström; S Normark
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

2.  The DD-carboxypeptidase-transpeptidase system in Escherichia coli mutant strain.

Authors:  J J Pollock; M Nguyen-Distèche; J M Ghuysen; R Linder; M R Salton
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

Review 3.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

4.  Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota
Journal:  J Antibiot (Tokyo)       Date:  1970-03       Impact factor: 2.649

5.  R factors, beta-lactamase, and carbenicillin-resistant Pseudomonas aeruginosa.

Authors:  R B Sykes; M H Richmond
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

Review 6.  The barrier function of the gram-negative envelope.

Authors:  L Leive
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

7.  Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea.

Authors:  L D Sabath; M Jago; E P Abraham
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

8.  Indirect method for assessing the penetration of beta-lactamase-nonsusceptible penicillins and cephalosporins in Escherichia coli strains.

Authors:  M H Richmond; D C Clark; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  Properties of a R factor which originated in Pseudomonas aeruginosa 1822.

Authors:  J Grinsted; J R Saunders; L C Ingram; R B Sykes; M H Richmond
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

10.  Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Authors:  H R Onishi; D R Daoust; S B Zimmerman; D Hendlin; E O Stapley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

View more
  23 in total

1.  The in vitro and in vivo Antibacterial Activity of Cefuroxime.

Authors:  S Goto
Journal:  Proc R Soc Med       Date:  1977

2.  Cefuroxime in the treatment of bacterial infections in seriously ill patients admitted to an intensive care unit.

Authors:  M Gobernado; J Gudin; M Santos; J Gregori; E Canton; C Ferrando
Journal:  Proc R Soc Med       Date:  1977

3.  Pharmacokinetic and clinical studies on cefuroxime.

Authors:  R Norrby; R D Foord; J D Price; P Hedlund
Journal:  Proc R Soc Med       Date:  1977

4.  β-Lactamase Resistant Cephalosporins with Particular Reference to Cefuroxime.

Authors:  M H Richmond
Journal:  Proc R Soc Med       Date:  1977

5.  Clinical experience in the treatment of pneumonia with cefuroxime.

Authors:  T Pettersson
Journal:  Proc R Soc Med       Date:  1977

6.  Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.

Authors:  R N Jones; P C Fuchs; T L Gavan; E H Gerlach; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

7.  Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase.

Authors:  K Tsukamoto; R Ohno; T Sawai
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

8.  Penetration of cephalosporins and corresponding 1-oxacephalosporins through the outer layer of Gram-negative bacteria and its contribution to antibacterial activity.

Authors:  K Murakami; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

9.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells.

Authors:  H Nikaido; E Y Rosenberg; J Foulds
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

10.  Polycations sensitize enteric bacteria to antibiotics.

Authors:  M Vaara; T Vaara
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.